Advanced Accelerator Applications

Quick facts

Marketed products

• arginine/lysine · Immunology
  Arginine and lysine are amino acids that support immune function and may enhance natural killer cell activity and protein synthesis.
• LUTATHERA
• L-Lysine · Metabolic
• PSMA-11 · Other

Phase 3 pipeline

• 177Lu-DOTA0-Tyr3-Octreotate · Oncology
  177Lu-DOTA0-Tyr3-Octreotate is a radiolabeled somatostatin analog that binds to somatostatin receptors on neuroendocrine tumor cells and delivers targeted radiation therapy.

Phase 1 pipeline

• [177Lu]-NeoB
• [68Ga]-NeoB
• [68Ga]-PSMA-R2

Competitive intelligence

For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors:

• Advanced Accelerator Applications portfolio CI brief
• Advanced Accelerator Applications pipeline updates RSS